[Exclusive] CJ and HDC to Wind Down Biodegradable Plastics Business Launched Jointly After 4 Years
BioSol, a Joint Venture Between HDC Hyundai EP and CJ CheilJedang, to Put Dissolution Proposal on the Agenda at Extraordinary General Meeting
Launched with PHA-based biodegradable compounding materials… Investing 24 billion won in Jincheon
Domestic Demand Fails to Pick Up Despite Regulatory Easing… Cumulative Net Loss of 2.2 Billion in the First Three Quarters of This Year
[Edaily Marketin Reporter LEE GEON-EOM ] #HDC Hyundai EP and #CJ CheilJedang’s joint venture, CJ HDC BioSol (hereinafter “BioSol”), established to develop biodegradable plastic materials, has begun the process of dissolution. Analysts suggest that the company has decided to wind down operations just four years after its launch, as the domestic market for its core materials failed to open up as expected.
Dissolution Proposal to Be Tabled at Extraordinary General Meeting… CJ Also Conducting ‘Strategic Review’
According to a compilation of E-Daily’s reporting on the 16th, Biosol held a board meeting on October 21 and decided to table a resolution for dissolution at
an extraordinary general meeting of shareholders
. CJ CheilJedang is also reportedly conducting
a
strategic
review
of winding down the business, as it deems it difficult to continue investing given the lack of domestic market growth and the business’s viability.
BioSol is a bio-compounding joint venture established in 2022, with HDC Hyundai EP and CJ CheilJedang contributing 51% and 49% of the capital, respectively. Compounding refers to the process of mixing two or more plastic materials in optimal proportions to achieve desired physical properties. (Photo: CJHDC BioSol) BioSol was tasked with blending other biodegradable materials, such as PLA and PBAT, with polyhydroxyalkanoate (PHA)—a marine-based biodegradable material produced by CJ CheilJedang—to create materials used in food packaging and automotive interior components. PHA is a polymer produced when microorganisms consume plant-derived components and accumulate them within their cells; it has the property of degrading in both soil and the ocean.
The two companies invested approximately 24 billion won to install equipment at HDC Hyundai EP’s plant in Jincheon, North Chungcheong Province, and completed a production line with an annual capacity of 11,000 metric tons in January 2023. Their plan was to combine CJ CheilJedang’s microbial fermentation technology with HDC Hyundai EP’s compounding capabilities to secure a leading position in the domestic biodegradable materials market.
Regulatory Rollbacks and Vanishing Demand… Mounting Losses
BioSol began considering dissolution because the domestic market for its flagship material never truly opened up. Demand for biodegradable materials was expected to rise in tandem with stricter regulations on single-use products, but policy directions changed repeatedly.
In 2022, the Ministry of Environment suspended eco-label certification for biodegradable products and limited the use of biodegradable bags at general retail stores, such as convenience stores, to 2024.
In November 2023, the government shifted its approach to managing single-use products from imposing fines to voluntary participation, excluded paper cups from the scope of regulations, and postponed enforcement against plastic straws. The explanation is that, since a system for separately collecting and processing biodegradable plastics had not been established, companies had little incentive to use biodegradable materials, which are more expensive than conventional plastics.
These circumstances are clearly reflected in the company’s financial performance. According to HDC Hyundai EP’s third-quarter report, BioSol posted sales of 4.3 billion won and a net loss of 3.1 billion won last year. In the first three quarters of this year, the company recorded sales of 2.6 billion won and a net loss of 2.2 billion won, continuing its string of losses. In other words, despite operating a facility with an annual production capacity of 11,000 metric tons, revenue remained in the range of several billion won. Biosol’s total capital decreased from 12.3 billion won at the end of last year to 10.1 billion won at the end of the third quarter of this year.
The value of HDC Hyundai EP’s stake in BioSol has also been significantly eroded. Although HDC Hyundai EP’s acquisition cost for BioSol was 12.2 billion won, the book value at the end of the third quarter stood at 2.3 billion won—a further decline from 3.4 billion won at the end of last year. As a result of recognizing losses using the equity method (an accounting method that reflects the investee’s profits or losses in proportion to the ownership stake), the book value has fallen to one-fifth of the acquisition cost.
The major shareholder also covered the operating funds. This year, HDC Hyundai EP lent Biosol 357 million won at an annual interest rate of 5 percent. The loan matures at the end of March next year. This indicates that the company was struggling to sustain its operations on its own revenue alone.
However, specific liquidation procedures—such as the schedule for the extraordinary general meeting and plans for disposing of the Jincheon plant’s facilities—have not yet been disclosed. Observers suggest that discussions between the two companies regarding how to settle the remaining assets and liabilities are still ongoing.
#HDC Hyundai EP and #CJ CheilJedang’s joint venture, CJ HDC BioSol (hereinafter “BioSol”), established to develop biodegradable plastic materials, has begun the process of dissolution. Analysts sugges…
LF achieved both revenue growth and improved profitability in the third quarter, driven by balanced growth across its in-house and imported fashion and beauty brands. LF(093050)According to the quarte…
RNA interference (RNAi) drug developer Olix Pharmaceuticals, Inc.(226950)is expanding its research and development of next-generation obesity treatments using adipose tissue-targeted RNAi technology.
…